BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28238520)

  • 1. Precision surgery and avoiding over-treatment.
    Hosseini A; Khoury AL; Esserman LJ
    Eur J Surg Oncol; 2017 May; 43(5):938-943. PubMed ID: 28238520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
    Martínez-Pérez C; Turnbull AK; Ekatah GE; Arthur LM; Sims AH; Thomas JS; Dixon JM
    Cancer Treat Rev; 2017 Apr; 55():163-172. PubMed ID: 28402908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actual management of ductal carcinoma in situ of the breast.
    Maass N; Alkasi O; Bauer M; Jonat W; Souchon R; Meinhold-Heerlein I
    Arch Gynecol Obstet; 2009 Nov; 280(5):699-705. PubMed ID: 19259692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.
    Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
    ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates in the treatment of ductal carcinoma in situ of the breast.
    Lebeau A; Kühn T
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):49-58. PubMed ID: 26694830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.
    Wilkinson JB; Vicini FA; Shah C; Shaitelman S; Jawad MS; Ye H; Kestin LL; Goldstein NS; Martinez AA; Benitez P; Chen PY
    Ann Surg Oncol; 2012 Nov; 19(12):3785-91. PubMed ID: 22644510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment.
    Silverstein MJ; Recht A; Lagios MD; Bleiweiss IJ; Blumencranz PW; Gizienski T; Harms SE; Harness J; Jackman RJ; Klimberg VS; Kuske R; Levine GM; Linver MN; Rafferty EA; Rugo H; Schilling K; Tripathy D; Vicini FA; Whitworth PW; Willey SC
    J Am Coll Surg; 2009 Oct; 209(4):504-20. PubMed ID: 19801324
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy is not a contraindication for nipple sparing mastectomy.
    Santoro S; Loreti A; Cavaliere F; Costarelli L; La Pinta M; Manna E; Mauri M; Scavina P; Santini E; De Paula U; Toto V; Fortunato L
    Breast; 2015 Oct; 24(5):661-6. PubMed ID: 26343944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence patterns in breast cancer patients treated with oncoplastic reduction mammaplasty and radiotherapy.
    Eaton BR; Losken A; Okwan-Duodu D; Schuster DM; Switchenko JM; Mister D; Godette K; Torres MA
    Ann Surg Oncol; 2014 Jan; 21(1):93-9. PubMed ID: 24081796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Involvement of the Nipple in Total Skin-Sparing Mastectomy: Strategies for Management.
    Amara D; Peled AW; Wang F; Ewing CA; Alvarado M; Esserman LJ
    Ann Surg Oncol; 2015 Nov; 22(12):3803-8. PubMed ID: 26023040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Gøtzsche PC
    J Natl Cancer Inst; 2004 Aug; 96(16):1257; author reply 1259-60. PubMed ID: 15316062
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Schwartz GF; Lagios MD; Silverstein MJ
    J Natl Cancer Inst; 2004 Aug; 96(16):1258-9; author reply 1259-60. PubMed ID: 15316064
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.